| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE | 73 |
| 1 | MORPHINE SULFATE | 25 |
| 2 | CLONAZEPAM | 23 |
| 3 | ALPRAZOLAM | 22 |
| 4 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 21 |
| 5 | NALTREXONE | 20 |
| 6 | GABAPENTIN | 19 |
| 7 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 17 |
| 8 | HYDROMORPHONE HYDROCHLORIDE | 17 |
| 9 | OXYCODONE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 1 | LENIOLISIB | 1 | 0.0011 |
| 2 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 9 | 0.0007 |
| 3 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 17 | 0.0007 |
| 4 | NALTREXONE | 20 | 0.0006 |
| 5 | ZIPRASIDONE | 2 | 0.0006 |
| 6 | EFINACONAZOLE | 1 | 0.0005 |
| 7 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 1 | 0.0005 |
| 8 | CLORAZEPATE DIPOTASSIUM | 1 | 0.0005 |
| 9 | VELAGLUCERASE ALFA | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 58 |
| 1 | Opioid Agonist [EPC] | 25 |
| 2 | Atypical Antipsychotic [EPC] | 20 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 18 |
| 5 | Partial Opioid Agonist [EPC] | 12 |
| 6 | Muscle Relaxant [EPC] | 9 |
| 7 | Corticosteroid [EPC] | 7 |
| 8 | Mood Stabilizer [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 2 | Muscle Relaxant [EPC] | 9 | 0.0002 |
| 3 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 4 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Partial Opioid Agonist [EPC] | 12 | 0.0001 |
| 6 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 5 | 0.0001 |